Zobrazeno 1 - 10
of 20
pro vyhledávání: '"S. D. Ladas"'
Autor:
G. Karamanolis, I. Delladetsima, V. Kouloulias, K. Papaxoinis, I. Panayiotides, D. Haldeopoulos, K. Triantafyllou, N. Kelekis, S. D. Ladas
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
Background. Inflammation mediators related to radiation proctitis are partially elucidated, and neovascularization is thought to play a key role. Objectives. To investigate the expression of vascular endothelial growth factor (VEGF) and CD31 as angio
Externí odkaz:
https://doaj.org/article/3238cf210da24acd8d82e901b2e46e54
Autor:
L B, Cohen, S D, Ladas, J J, Vargo, G A, Paspatis, D J, Bjorkman, P, Van der Linden, A T R, Axon, A E, Axon, G, Bamias, E, Despott, M, Dinis-Ribeiro, A, Fassoulaki, N, Hofmann, J A, Karagiannis, D, Karamanolis, W, Maurer, A, O'Connor, K, Paraskeva, F, Schreiber, K, Triantafyllou, N, Viazis, J, Vlachogiannakos
Publikováno v:
Alimentary pharmacologytherapeutics. 32(3)
Guidelines and practice standards for sedation in endoscopy have been developed by various national professional societies. No attempt has been made to assess consensus among internationally recognized experts in this field.To identify areas of conse
Publikováno v:
Journal of musculoskeletalneuronal interactions. 8(1)
Most studies have shown contradictory results regarding predictive factors of osteoporosis in inflammatory bowel disease (IBD). Since in these studies either T- or Z-scores has been used, our aim was to compare T- and Z-score in identifying risk fact
Autor:
D G, Karamanolis, Ioannis, Kyrlagkitsis, K, Konstantinou, G V, Papatheodoridis, A, Karameris, E, Mallas, S D, Ladas, S, Raptis
Publikováno v:
Hepato-gastroenterology. 54(76)
Ulcerative colitis (UC) constitutes a chronic inflammatory process of the colon of unknown etiology. Current data support a pivotal role of apoptosis in the evolution of pathogenesis of UC. We performed a prospective study in order to determine the r
Autor:
S D, Ladas, B, Novis, K, Triantafyllou, R, Schoefl, T, Rokkas, C, Stanciu, P, Isaacs, S N, Willich, O, Ronn, H, Dremel, G, Livadas, B J, Egan, S, Boyacioglu, A, Selimovic, R, Pulanic, J A, Karagiannis, J P, Van Vooren, E, Kouroumalis, C, O'Morain, A, Nowak, J, Deviere, P, Malfertheiner, A, Axon
Publikováno v:
Endoscopy. 39(6)
Autor:
S D, Georgopoulos, S D, Ladas, S, Karatapanis, K, Triantafyllou, C, Spiliadi, A, Mentis, V, Artikis, S A, Raptis
Publikováno v:
Alimentary pharmacologytherapeutics. 16(3)
There are no guidelines on second-line therapies for Helicobacter pylori eradication failures of omeprazole-clarithromycin-amoxicillin triple therapy.To compare the efficacy of two second-line therapies for persistent H. pylori infection.Over a 6-yea
Publikováno v:
Digestive diseases and sciences. 46(7)
There is evidence that Helicobacter pylori eradication might predispose to gastroesophageal reflux disease (GERD). The aim of this prospective study was to examine the effectiveness of antisecretory treatment, after successful H. pylori eradication,
Publikováno v:
Digestive diseases and sciences. 45(12)
Normal subjects may incompletely absorb either lactose, fructose, or sorbitol and may therefore have abdominal symptoms. The frequency of coincidental malabsorption of these sugars is not known. This is clinically important, since we often ingest the
Autor:
S D, Georgopoulos, S D, Ladas, S, Karatapanis, A, Mentis, C, Spiliadi, V, Artikis, S A, Raptis
Publikováno v:
Digestive diseases and sciences. 45(1)
Factors affecting Helicobacter pylori eradication rate with omeprazole (OME), clarithromycin (CL), and amoxicillin (AMO) have not been extensively studied. We have investigated the effect of age, sex, smoking, ulcer disease, compliance with therapy,
Publikováno v:
The American journal of gastroenterology. 95(2)
Treating patients with erosive esophagitis and maintaining remission in a cost-effective fashion is a desirable goal in clinical practice. There are no established criteria to identify patients with healed esophagitis who will subsequently remain in